Top 50 Medical VC (Venture Capital) Funds in Sweden in July 2025
A list of 50 VC (Venture Capital) funds that invest in Medical startups based in Sweden. We rank investors based on the number of investments they made in Medical companies from Sweden. We update this investor list every month.Top 50 Medical VC (Venture Capital) Funds in Sweden in July 2025
Investor | Medical Sweden investments |
---|---|
Almi Invest | 12 |
Chalmers Ventures AB | 10 |
Sciety | 8 |
SEB Venture Capital | 5 |
Hadean Ventures | 4 |
Sweet Studio | 4 |
Norrsken VC | 3 |
Karolinska | 3 |
Crowberry Capital | 3 |
Bonit Capital | 3 |
Partnerinvest Norr | 3 |
Inventure | 3 |
Industrifonden | 3 |
Fåhraeus Startup and Growth | 2 |
Jovitech Invest | 2 |
Uppsala universitet Invest AB | 2 |
Scale Capital | 2 |
Metsa Spring | 2 |
Index Ventures | 2 |
Creandum | 2 |
Otiva | 2 |
Noaber | 2 |
Project A Ventures | 2 |
Heartcore Capital | 2 |
GU Ventures | 2 |
Sting Capital | 2 |
3T Invest | 2 |
Forbion Capital Partners | 1 |
BackingMinds | 1 |
Bonnier Ventures | 1 |
Walking Ventures | 1 |
Novo Holdings | 1 |
Tham Invest | 1 |
Flerie Invest | 1 |
Sweet Capital | 1 |
DHS Venture Partners | 1 |
20 North Street | 1 |
Ferd | 1 |
SmiLe Inject Capital | 1 |
Innovations Kapital | 1 |
KTH Holding | 1 |
Accel | 1 |
Gamlegård Invest | 1 |
Zentynel Frontier Investments | 1 |
HealthCap | 1 |
Dendera Ventures | 1 |
Teknoinvest | 1 |
Nordic Science Investments | 1 |
Faro Capital | 1 |
Segulah Medical Acceleration | 1 |
Almi Invest is Sweden’s most active early-stage venture capital firm, investing in scalable startups across Sustainability, Industry, Tech, and Life Science.We invest from pre-seed to Series A, always co-investing with independent private investors to accelerate innovation and long-term success. Our portfolio spans sustainable solutions,industrial innovation, deep tech, SaaS, and life science, supporting startups that drive economic and environmental progress.With €430 million under management and over 1,000 investments since 2009, we have backed leading companies like MIPS, Tobii, and Neo4j, with notable exits to Google, Apple, Microsoft, and Qlik.Beyond capital, we offer engaged ownership, providing strategic guidance, active board participation, and access to an extensive investor network.Almi Invest is part of the Almi Group and is funded by the European Regional Development Fund, Almi AB, and regional partners.
Show more
Investment focus
- Software, Health Care, Information Technology
- Funding Round, Seed, Pre-Seed
- Sweden, United States, United Kingdom
Portfolio highlights
- Embedl AB — Efficient Deep Learning by Deep Learning model optimization
- Epigenica — Epigenica focuses on advancing epigenomics through its EpiFinder™ platform, a multiplexed ChIP-seq technology for high-throughput analysis of epigenetic marks. The company offers R&D services for the development of therapeutic molecules and diagnostic methods using epigenetics. Epigenica aims to improve scientists' ability to capture andextract insights from the epigenome, contributing to precision medicine and the discovery of new biomarkers.
- Polar Light Technologies — Polar Light Technologies focuses on developing the next generation of Nano and micro LED technology.
We are a leading tech investor & venture builder in the Nordics. Taking deep tech from lab to market.WELCOMEINVESTMENTS
Show more
Investment focus
- Software, Biotechnology, Information Technology
- Pre-Seed, Seed, Funding Round
- Sweden
Portfolio highlights
- Embedl AB — Efficient Deep Learning by Deep Learning model optimization
- Adsorbi — Adsorbi use cellulose from the Nordic forest to help air purification companies to capture gaseous air pollutants.
- Swedish Algae Factory — Our algae materials replace harmful and less efficient chemicals in high-end organic personal care products and has the potential of increasing the efficiency of solar panels.
Whether you are an investor or entrepreneur, partner with Sciety to achieve impactful returns and elevate your life science business in the Nordics.
Show more
Investment focus
- Health Care, Biotechnology, Pharmaceutical
- Seed, Series A, Funding Round
- Sweden, Ukraine
Portfolio highlights
- Capitainer — Capitainer enables patients to collect their own volume-defined dried blood spot at home.Capitainer started in 2016. Their technology is a volumetric blood collection device that enables patients to conveniently and safely collect blood samples in the comfort of their own home, our technology is more accurate than today’s solutions. Capitaineroffers impressive cost and environmental savings for healthcare providers managing millions of conventional blood samples annually.
- PeptiSystems — PeptiSystems offers a new generation of instruments for solid-phase synthesis production of peptide and oligonucleotide therapeutics. Our instruments are used for process development and large-scale GMP and non-GMP manufacturing based on flowthrough column technology.
- TIRmed Pharma — TIRmed Pharma develops drug candidates addressing major clinical needs.
SEB Venture Capital is a Fintech investor that helps entrepreneurs and innovators launch and grow profitable businesses. They primarily serve as a strategic corporate venture focused on Fintech investments, with the option of partnering with SEB. They are also on the hunt for game-changing inventive solutions to new technologies that will make thefinancial industry smarter, safer, and more environmentally responsible, as well as more user-friendly. They also function as an evergreen fund, giving them the flexibility and staying strength to focus on long-term wealth development depending on what is best for the firm and its shareholders.
Show more
Investment focus
- Software, Information Technology, Financial Services
- Funding Round, Series A, Series B
- Sweden, Denmark, United Kingdom
Portfolio highlights
- EnginZyme — EnginZyme is a biotechnology company that specializes in biocatalysis. It creates products for easy and cost-efficient implementation of biocatalytic processes and helps the chemical industry transition to a sustainable way of operating.The company is driven by a mission to make biocatalysis the first choice for chemical process designersworldwide.
- Qvantum — Qvantum is driven by a passion for a sustainable future and we are changing the way the cities of Europe are heated.
- CorPower Ocean — CorPower Ocean is a turnkey supplier of wave energy systems, enabling customers to generate clean electricity from ocean waves - bringing stability to the renewable energy mix.
Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region.
The funds are backed by leading private and institutional investors.
Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across theregion
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Series A, Funding Round, Series B
- Sweden, Norway, Austria
Portfolio highlights
- SciRhom — SciRhom GmbH is a biotech company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening autoimmune diseases. Based on longstanding academic research and a well-established network of experts, SciRhom was founded in 2016 through a collaboration between academicand industry scientists with profound experience in antibody development.
- Gesynta Pharma — Founded in 2017, Gesynta Pharma bases its R&D on research from the Karolinska Institutet. The most advanced drug candidate, GS-248, reduces inflammation and increases blood flow in the microvasculature, thereby having the potential to provide improved treatments for several serious diseases. In an ongoing clinical proof-of-concept study,GS-248 is being evaluated for its capacity to normalize vascular blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. Positive results from this study may lead to a rapid broadening of the development program towards additional indications, for example cardiovascular diseases and rheumatic diseases other than systemic sclerosis. Major shareholders include Industrifonden, Linc, Hadean Ventures, and a number of successful life science entrepreneurs. For more information, please visit www.gesynta.se
- Alex Therapeutics — The Alex DTx Platform enables partners within pharma and health care to effectively and reliably launch new DTx treatments by leveraging existing insights, modules, processes and data.
We co-found companies, dedicating our in-house team of designers, developers, and marketers to bring ideas to life.
With every venture we co-found, our mission is to advance the consumer experience across industries with world-class technology, data-informed design, and lots of heart. Are you an entrepreneur who shares our mission?
Show more
Investment focus
- iOS, Mobile Apps, Artificial Intelligence
- Pre-Seed, Funding Round
- Sweden
Portfolio highlights
- Koo! — Koo! is an audio based social networking service that let users record and listen to 1-minute audio clips called Koos.
- Alex Therapeutics — The Alex DTx Platform enables partners within pharma and health care to effectively and reliably launch new DTx treatments by leveraging existing insights, modules, processes and data.
- Stride Leadership — Stride is the revolutionary leadership product built to help become a confident leader. For too long, we’ve been taught that leadership is an elite act that’s linked to your job title. Now you hold leadership development in your hand, regardless of your age, job title, or seniority.With Stride, you’ll learn what it truly means to lead, and how todo it. We’ll bust common myths and you’ll discover which style of leadership is the best fit for you. Designed by leadership and design experts, Stride will help you learn the mindset required, the basics of leadership, and techniques for dealing with inevitable challenges. Whether you’re new to leadership or you’re a seasoned professional you’ll love learning and forming new habits with Stride.
We are a venture capital fund investigating in Start-Ups solving the worlds biggest problems while building massive businesses.
Show more
Investment focus
- Software, Food and Beverage, Health Care
- Seed, Series A, Funding Round
- Sweden, Germany, United Kingdom
Portfolio highlights
- Kapu — We are an online shopping community that helps you save even more on your everyday essentials when you buy together with your friends.
- trawa — The partner for renewable and affordable electricity for businesses. Get electricity directly from solar and windparks with corporate PPAs.
- Beans — Beans is on a mission to help the planet by reducing food waste, saving products, and offering them through an online grocery platform at discounted prices.
Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatestreturn on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB.The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced.The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companiesKarolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects.
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Funding Round, Seed, Series A
- Sweden, Denmark, United States
Portfolio highlights
- PharmNovo — Latest News from PharmNovo. Learn more about pain, neuropathic pain, chronic pain. Treatment with our lead candidate PN6047. Therapy market, our networks. There is a huge unmet medical need for people suffering from chronic pain.
- OssDsign AB — Giving patients back the life they deserve, Catalyst nanosynthetic bone graft, orthobiologics
- Modus Therapeutics — Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
Crowberry Capital invests at seed and early stage in emerging technology ventures in the Nordics. Our mission is to back people that are good for companies and build companies that are good for people. We have a strong follow-through philosophy and commit to putting your company first.
Show more
Investment focus
- Software, Gaming, Health Care
- Seed, Series A, Pre-Seed
- Iceland, Denmark, Finland
Portfolio highlights
- Tiimo — Tiimo helps you manage your daily life and improve your wellbeing. Visualize your day. Improve your routines. Stress less.
- Quanscient — We are building next generation simulation software-as-a-service utilizing Quantum computing algorithms. Our specialty domain of simulations is Computational Electromagnetics.
- Porcelain Fortress — Porcelain Fortress was founded by a small band of romantics in the summer of 2016 in Reykjavik, Iceland.
Bonit Capital is a Swedish family-owned investment company. We invest across sectors and asset classes, including social investments and outcome models.Venture Capital - We invest in ambitious founders within the life science sector. We take an active ownership approach by providing capital, industry expertise and access to an internationalnetwork. Our focus areas are digital health, medical technology and diagnostics.Private Equity - We invest in entrepreneurial teams with deep sector expertise and unique market access, primarily in the lower to mid-market buyout segment, with the aim to produce superior returns and meaningful portfolio diversification.Listed Equity - Our strategy is to obtain a broad market exposure through mainly external mandates, and to seek superior returns in individual shares primarily in life science. Among Bonit's main holdings are the world-leading medtech company Elekta AB, founded by Laurent Leksell.Leksell Social Ventures - LSV is the first impact investor in Sweden with a focus on outcome models and direct investments in the areas of mental health, education and social integration. Striving for systemic change, LSV contributes to social innovation and societal development by giving social entrepreneurs and social ideas the necessary prerequisites to develop and progress – through financing, idea development and networking with private, public and nonprofit actors.
Show more
Investment focus
- Health Care, Medical, Apps
- Funding Round, Seed, Series A
- Sweden, United States, Germany
Portfolio highlights
- Vården.se — Vården.se is Sweden's largest private search service in healthcare and health .
- Bentley — Bentley engages in the development, manufacturing for minimal-invasive treatments of vascular diseases.
- Alex Therapeutics — The Alex DTx Platform enables partners within pharma and health care to effectively and reliably launch new DTx treatments by leveraging existing insights, modules, processes and data.
Partnerinvest Norr is a private equity firm specialized in software, security, and biometrics sectors.
Partnerinvest Övre Norrland AB is a venture capital firms that seeks to invest in limited companies which have are in the expansion phase.
Show more
Investment focus
- Software, Information Technology, Manufacturing
- Seed, Funding Round, Series A
- Sweden, United States
Portfolio highlights
- Elastisys — Succeed with your cloud native journey as an organization developing and operating software critical to our society. NIS2, ISO-27001, GDPR.
- Senseworks — Senseworks is an insight platform that enables colleagues to collaborate effectively with customers by providing a single source of truth for accounting data.
- Cold River Games — Cold River Games is a Swedish game studio currently developing the ARPG Crystalfall.
Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.
Show more
Investment focus
- Software, Information Technology, Health Care
- Seed, Series A, Series B
- Finland, Sweden, Denmark
Portfolio highlights
- Hedera Dx — A diagnostics platform that makes liquid biopsies a reality in cancer care
- Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol
- Avenue Biosciences — From biotechnology tools to therapy discovery and development: Our platform enhances production yield and the quality of your end product.
Industrifonden is a Nordic evergreen venture capital firm with a fund size of $600m, that focuses on early-stage technology and life science companies with international potential. The company works long term with the entrepreneurs we invest in, and have a strong track record of building game changing companies. Industrifonden-backed companiesinclude tech companies Qlik, Arcam, Soundtrack Your Brand, Fishbrain, and life science companies CellaVision, Oncopeptides and AMRA.
Show more
Investment focus
- Software, Biotechnology, Information Technology
- Funding Round, Series A, Seed
- Sweden, United States, Denmark
Portfolio highlights
- Fibbl — Fibbl is the world's first cost-effective end-to-end solution for 3D and AR focused visual marketing. Integrate 3D & AR into e-commerce and marketing in minutes.Fibbl have industrialized the process of producing photorealistic 3D models for consumer products from global brands. Fibbl has the world's largest 3D model database forconsumer products.Learn more - https://www.fibbl.com/
- Gårdsfisk — Gårdsfisk is a company managing fishing farms. Gårdsfisks develops a new method for fish farming on land. The cultivation takes place in large pools in a closed system, where the nutrient residual water can be reused as fertilizer on the fields.
- Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.
Fåhraeus Startup and Growth is a venture capital fund that invests early in life science and tech companies.
Show more
Investment focus
- Medical, Health Care, Organic Food
- Funding Round, Seed
- Sweden
Portfolio highlights
- Aplagon — Aplagon is committed to bringing unique, effective antithrombotic medicines with important safety advantages to patients with unmet needs.
- Airsonett — Research-based medical technology company which leads the way in the development of non-pharmaceutical treatment for allergic asthma.
- Nygen Analytics — Nygen empowers researchers to unlock insights from single-cell RNA-seq data with accessible, no-code solutions, facilitating reproducible transcriptomic research.
Jovitech Invest help entrepreneur-led companies to grow profitably through active, long-term ownership
Show more
Investment focus
- Solar, Medical, Recycling
- Seed
- Sweden
Portfolio highlights
- Adsorbi — Adsorbi use cellulose from the Nordic forest to help air purification companies to capture gaseous air pollutants.
- Mat4Green Tech — Mat4Green Tech develops a technology that recycles Indium from industrial waste in an efficient and climate-neutral way.
Uppsala universitet Invest AB focuses on investment management, particularly in early-stage ventures. The company collaborates with researchers and students, providing financial support and strategic guidance for innovative projects. It aims for long-term investment horizons, typically ranging from 5 to 15 years. Uppsala universitet Invest AB alsopartners with other investors and co-financiers to support research-driven initiatives.
Show more
Investment focus
- Medical, Health Care, Health Diagnostics
- Seed
- Sweden
Portfolio highlights
- SampleFacts — Next generation Dried Blood Spot sampling – separating cells and plasma at the point of collection.
- Readily Diagnostics — Readily Diagnostics develops speedy and accurate diagnostic tests for respiratory disorders, enabling faster and more effective therapy at the point of care.
Scale Capital is an early-stage technology investor, helping Nordic, B2B, and tech founder teams scale and win in the US market.
Show more
Investment focus
- Software, Information Technology, SaaS
- Seed, Funding Round, Pre-Seed
- Denmark, Norway, Sweden
Portfolio highlights
- All Gravy — Butter gives you happier employees, by reducing their financial stress and giving them an understanding of their salary and financial situation
- Players 1st — Join 3000 golf clubs using Players 1st to boost your business with pre-made surveys, smart analytics, and benchmarks, capturing real-time golfer feedback!
- Telescope — A practical tool for managing sustainability risk in real estate
We boldly invest in and support promising startups and potential innovations that explore new uses for sustainably-grown Nordic wood.
Show more
Investment focus
- Sustainability, GreenTech, Chemical
- Seed, Funding Round, Series A
- Finland, Sweden
Portfolio highlights
- Adsorbi — Adsorbi use cellulose from the Nordic forest to help air purification companies to capture gaseous air pollutants.
- FineCell — FineCell is a sustainable cellulose microfibers provider that enables manufacturers to make new products with reduced carbon footprints and differentiated properties.The company's cellulose microfibers possess physical and chemical properties that differ from competing products and provide differentiated benefits for the users. It has beensupported by Vinnova (Sweden’s innovation agency) and EIT InnoEnergy.The Linköping, Ostergotlands Lan-based company was established in 2015 by Jonatan Henschen, Jonas Engstrand, Monica Ek, and Kloce Dongfang Li.
- Fiberwood — Fiberwood is a new eco-friendly wood fiber insulation that can be used for a variety of purposes. Fiberwood has excellent insulating properties, is entirely bio-based, and thus contains no plastic or other fossil-based materials.
Index Ventures is an international venture capital firm with dual headquarters in San Francisco and London, investing in technology-enabled companies with a focus on e-commerce, fintech, mobility, gaming, infrastructure/AI, and security.
Show more
Investment focus
- Software, E-Commerce, Internet
- Series A, Series B, Seed
- United States, United Kingdom, France
Portfolio highlights
- Boulevard — Boulevard is the first and only Client Experience Platform. Streamline bookings, optimize your schedule, and drive growth with a complete platform built just for you
- Moment — Engineering the future of fixed income with the world's leading financial institutions.
- Bigger Games — Bigger Games, a dynamic mobile gaming company, is at the forefront of transforming the mobile gaming landscape. We aim for great execution and passionately work on each and every detail in our casual games to build the best experience for our players.
We support early-stage founders in building global, category-defining companies. From Seed to IPO and beyond.
Show more
Investment focus
- Software, Information Technology, FinTech
- Series A, Seed, Series B
- Sweden, Germany, United States
Portfolio highlights
- Laka — Laka is collective bicycle insurance especially for cyclists. We flipped insurance. By making it pay to pay out, we are the collective that backs each other. Protect your bikes and gear against theft & damage with Laka 5-star rated cycle insurance.
- CarOnSale — Operator of B2B auction platform intended to digitize the lease-return and trade-in of cars.
- Lovable — Build software products, using only a chat interface
Equity investment company doing Series A to late growth, private and public. Agile and long-term with no fixed holding period.
Show more
Investment focus
- Fashion, Lifestyle, Marketplace
- Seed, Series A, Series B
- Sweden, France
Portfolio highlights
- BlaBlaCar — BlaBlaCar is the world’s leading long-distance carpooling community, connecting people looking to travel long distances with drivers going the same way. They travel together and share the costs of the journey. The platform is engineered to create a secure, trust-based community with declared identities and full member profiles. Members can evenspecify how chatty they are from “Bla” to “BlaBlaBla”, hence the name BlaBlaCar. BlaBlaCar is creating a global people-powered network with a trusted community of drivers and passengers.Backed by Accel Partners, Insight Ventures, Index Ventures, Lead Edge Capital, Baring Vostok and ISAI, it operates in 22 countries across Europe, Russia, Turkey, Mexico, Brazil and India. The site and free mobile apps provide a range of features to create a secure, trust-based community and easy connections between drivers and passengers.BlaBlaCar is based in Paris with offices across a dozen of countries.
- NA-KD.com — NA-KD.com is the next generation of fashion marketplaces. A predominantly mobile-based online shopping sanctuary for fashion addicts all over the world. Combined with a unique merchant service that unleashes the e-commerce power of digital brands and social influencers. Funded by the original founder and team behind Nelly.com (170 million USDonline fashion store).
- Pet Media Group — Woof Woof. Europe's Largest Pet Marketplaces PetMediaGroup is the leading operator of online marketplaces for pets and related goods and services. Through our trusted and local brands, we help thousands of animals every day to find a new loving home as well as assist their human caregivers
Noaber Ventures invests in initiatives that bring social transformations using information technology.
Show more
Investment focus
- Health Care, Medical, Fitness
- Seed, Series A, Funding Round
- The Netherlands, Israel, Sweden
Portfolio highlights
- Newsenselab (M-sense) — M-sense is a certified medical app to combat migraines and headache. Our goal is to reduce 50% of headache days through a personalized therapy program - all in-app.
- Elsa — Elsa is a platform for patient driven research for better drugs, health and prevention. Elsa lets patients become their own personal researchers by providing them with a better understanding around how lifestyle factors may affect their disease activity measurements for chronic disease. To support them from a scientific perspective, Elsa gives themaccess to data on their specific disease (initially we work with rheumatoid arthritis) through the Riskminder foundation and scientific studies at Karolinska Institutet.
- Alba Health — Discover your baby's gut health & microbiome for the best start in life.
Project A is an early-stage venture capital firm, combining financial and operational support for technology companies. In addition to $1bn in assets under management, Project A provides its portfolio companies with a wide range of operational support services. This includes more than 100 experts from key areas such as software engineering,business intelligence, marketing, and recruiting. The portfolio includes companies such as Trade Republic, sennder, KRY, Catawiki, WorldRemit, Spryker, and Voi.
Show more
Investment focus
- Software, E-Commerce, Information Technology
- Seed, Series A, Series B
- Germany, United Kingdom, United States
Portfolio highlights
- avoltra — Avoltra aims to position itself as an "intelligent energy purchasing solution" by leveraging advanced technology and data-driven insights to optimize energy procurement.
- Montamo — Montamo trains lateral entrants with standardized methods. We rely on both our on-site academy and our digital learning software.
- Atmen — Atmen, formerly known as Point Twelve, automates hydrogen and e-fuels certification, saving you up to 90% time in the process.
Heartcore Capital invests in companies re-enchanting the world through technology.
Show more
Investment focus
- Software, FinTech, Artificial Intelligence
- Seed, Series A, Series B
- Denmark, United States, Germany
Portfolio highlights
- PhaseTree — Materials design simulation company - PhaseTree ApS
- Veda — Veda is the largest vault infrastructure platform in DeFi, enabling institutions to launch and manage onchain financial products at scale.
- Superform Labs — THE UNIVERSAL INTERFACE FOR YIELD IS FORMING
GU Ventures build businesses out of groundbreaking ideas that help shape a better tomorrow. Our passionate team of company builders, financial experts, IP and legal talent ensure success for our companies.
Show more
Investment focus
- Health Care, Pharmaceutical, Eyewear
- Seed, Funding Round
- Sweden
Portfolio highlights
- OnDosis — An intuitive dosage manager that helps patients optimize their treatment outcomes. Closing the loop between patient and physician.
- Profundus Imaging — Profundus' retinal imaging technology enables researchers and clinicians in particular to visualise subclinical changes of retinal disease.
- Thioredoxin Systems — Thioredoxin Systems AB is developing an innovative antibiotic regimen for complicated urinary tract infections caused by antibiotic-resistant bacteria. The
Sting – Stockholm Innovation & Growth enables talented people to turn their ideas into sustainable businesses. The support they offer includes qualified coaching in business development, a business angel network, a venture capital fund, a recruitment service, and an international network of investors, business contacts and experts. Itcontribute to the success of Sweden’s future technology companies by helping them to grow and compete internationally.
Show more
Investment focus
- Software, Apps, Medical
- Funding Round, Seed, Pre-Seed
- Sweden
Portfolio highlights
- Prion — Prion makes it quick and easy for the preschool staff to give parents insight into what happens at preschool - together with the children. The app is available free for iPhone, Android and iPad.
- Texelio — Texelio a company who is set to redefine financial market news by developing AI which empowers the customers of Retail banks, Online Brokers and Investment Service platforms.
- Minnemera — Minnemera develops digital neurocognitive tests.
3T Invest started an interesting and fulfilling journey back in 2009. From the beginning they focused on the establishment of sustainable Venture Capital, supporting innovation and entrepreneurship. they are always committed to backing outstanding entrepreneurs with the necessary resources.
Show more
Investment focus
- Medical, Health Care, Lifestyle
- Seed, Series A
- Sweden
Portfolio highlights
- Linkura — Linkura offers a Lifestyle Program focusing on actions.
- Werlabs — Werlabs is a Stockholm based medical technology company founded by Will Stoddart and Rickard Lagerqvist, a general practioner. Werlabs provides customers with health analysis via blood testing. The company’s aim is to give users the tools and information to take care of their health.
Impacting the future of medicine.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Series C
- United States, United Kingdom, The Netherlands
Portfolio highlights
- Azafaros — Azafaros aims at developing therapeutic agents for the treatment of rare metabolic disorders such as lysosomal storage disorders through oral administration of azasugar compounds. These novel, very promising agents were discovered by Professor Hans Aerts at Leiden University and Amsterdam UMC and are exclusively licensed to Azafaros.
- Eeden — Eeden engages in the manufacture and supply of textiles.
- Granite Bio — Targeting fundamentals of Inflammation, Autoimmunity and Fibrosis. Granite Bio develops first-in-class therapeutic antibodies depleting pathogenic cells with the potential to transform inflammatory and fibrotic diseases.
We help great minds unleash their full potential!
Show more
Investment focus
- Medical Device, SaaS, Information Technology
- Seed, Funding Round, Pre-Seed
- Sweden, Denmark, Finland
Portfolio highlights
- Uniqkey — Uniqkey provides a security management platform that automates employee logins to make businesses secure and productive. It simplifies employee security while empowering companies with enhanced control over their cloud infrastructure, access security, and employee management.Recognized as the easiest tool, Uniqkey removes friction from employees’daily workflows by automating time-consuming authentication and security tasks, thereby increasing productivity. Its intuitive and user-friendly interface makes Uniqkey the perfect choice for employees.Uniqkey combats the most significant threats to company infrastructure by safeguarding critical systems and company credentials with state-of-the-art encryption. It also offers unique insights and a comprehensive view of IT infrastructure, employee access, and security scores, making it a valuable tool for IT teams to monitor security policies and confidently assess the impact of awareness campaigns.With powerful integrations and synergies with existing infrastructure such as Microsoft, IT managers can quickly provision or de-provision users for seamless onboarding and offboarding, all while protecting their entire IT infrastructure with advanced encryption.Trusted by 500+ European businesses and ranked as a Top 50 Global Security Solution by G2, our platform is becoming Europe's preferred business password and access management solution.
- NitroVolt — NitroVolt: the next generational step of sustainable ammonia.
- Serviceform — Welcome to future of communication - the truly all-in-one conversion and management software built for established businesses. Start now!
Bonnier Capital is the investment division of the Bonnier Group. Since 2016, we invest in promising companies in structurally growing industries and have become a reliant investment partner to companies of various sizes.
Show more
Investment focus
- E-Commerce, Internet, Digital Media
- Funding Round, Seed, Series A
- Sweden, Finland, Germany
Portfolio highlights
- Airmee — Airmee provides a new last mile delivery solution. Whether you want to integrate Airmee into your webshop or simply book a local delivery today, we’ve got you covered. Airmee gives customers more – a great deal more – choice and convenience. Items when you want them. Where you want them. In as fast as an hour.
- MatHem — MatHem is an e-commerce company that combines a complete grocery store online with recipes and subscriptions for ready-made groceries. It delivers food to Swedish homes 7 days a week. The company also combines a full grocery store online with prescription and subscription finished shopping bags. MatHem offers a broad range of grocery products andadjacent household consumables, catering to more than half of Swedish households. The company food is delivered to your door with their own temperature-controlled to ensure an unbroken cold chain.Mathem.se has been awarded The Grocery Website of the Year (Årets matsajt) in 2010, 2011 and 2013 by the Swedish online magazine Internet world. It was founded in 2009 and is based in Stockholm, Sweden
- Natural Cycles — Natural Cycles birth control is 93% effective with typical use and 98% effective with perfect use. Learn more about hormone-free birth control today.
Walking Ventures is a seed fund which invests in early-stage Internet and other technology startups based in Europe.
The fund is a private vehicle controlled by Tim Jackson, a leading figure in the European technology scene as a venture capitalist, entrepreneur, angel investor, commentator and technology journalist.
Show more
Investment focus
- Software, Health Care, Internet
- Seed, Series A, Angel
- United Kingdom, United States, Sweden
Portfolio highlights
- Oviva — Oviva is digitizing the treatment of type 2 diabetes and obesity through a unique behavior change platform.They have developed unique, personalised behaviour change programmes that combine smartphone app and learning portals to support dietitian-led behaviour change for conditions such as type 2 diabetes and complex obesity. Their approach allowspatients to achieve a better health outcome without having to attend clinic appointments, whilst saving health systems significant sums by preventing the development of complications related to these health conditions.Oviva was founded in 2013 and is based in London, England.
- Tessian — Tessian enterprise email security protects employees from themselves. DLP and spear phishing protection. Automatically detect email threats.
- Attractions.io — Smart technology to deliver a better guest experience, increase secondary spend and understand visitor behaviour like never before.
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- United States, Denmark, United Kingdom
Portfolio highlights
- Supira Medical — Next Generation Solution for Temporary Mechanical Circulatory Support Developing a low-profile, high-flow percutaneous ventricular assist device (pVAD) for high risk coronary intervention and cardiogenic shock. Clinical Need Percutaneous ventricular assist devices (pVADs) are placed to provide temporary mechanical support, assisting the native pumping action of
- Sparrow Quantum — Sparrow Quantum, a global leader in quantum photonic chip technology. Explore innovative solutions driving advancements in quantum computing, communication, and beyond. Stay ahead with cutting-edge technologies shaping the future.
- Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.
Tham Invest is an investment firm.
Show more
Investment focus
- Medical, Wellness, Health Care
- Pre-Seed
- Sweden
Portfolio highlights
- Letterlife — Letterlife is a unique tool and community designed to empower and support females with ADHD.The platform offers a range of resources and support, including coaching, online courses, and a community forum where women can connect with others who share similar experiences. Through Letterlife, women with ADHD can learn strategies to manage theirsymptoms, gain confidence, and build a strong sense of community.
Flerie is an active long-term life science investor, focusing on biotech and pharmaceutical investments globally.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Funding Round, Series B
- Sweden, Israel, Iceland
Portfolio highlights
- Microbiotica — Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers. The company's therapeutics identify gut bacteria linked to phenotype with unprecedented precision, enabling researchers to phenotype before testing of candidate bacteria in advanced human in vitro and invivo models.
- Synerkine Pharma — Synerkine Pharma. Connecting Cytokines for the benefit of patients.
- Vitara Biomedical — Vitara Biomedical has developed a therapeutic platform to support premature infants. Vitara Biomedical's platform was inspired by natural physiological processes to transform neonatal care.
Sweet Capital is the private investment fund of the founders of King.com (Candy Crush Saga), following their $5.9b sale to Activision Blizzard in 2015 (ATVI:US; acq. MSFT:US).
Show more
Investment focus
- Apps, Software, Mobile
- Seed, Series A, Funding Round
- United States, United Kingdom, Israel
Portfolio highlights
- Pachama — Harnessing AI to drive carbon capture and protect global forests
- The Expert — Book consultations with the world's top design experts
- Masters — Train mind and body on the Masters app with full workout programs designed and run by the world's best athletes. Join today and start training like a pro.
DHS Ventures, Stockholm School of Economics alumni angel investing network that invests early on into inovative companies.
Show more
Investment focus
- Software, Big Data, Mobile Apps
- Funding Round, Pre-Seed, Seed
- Sweden
Portfolio highlights
- Divly — Crypto taxes without the headache. Divly simplifies and automates declaring taxes on your crypto trading.
- Normain — Normain is the AI platform for deep knowledge work. Automate your complex analyses and reports directly on Sharepoint or Google Drive. Access your own data and public sources in one single platform.
- Circulate — Find the best packaging for you and the planet in our marketplace
20 North Street is the name HDR Partners uses when adding investors and industrial experience to small growth companies.
Show more
Investment focus
- Medical, mHealth, Wireless
- Funding Round
- Sweden
Portfolio highlights
- Coala Life — Coala Life is a Swedish medical technology and life science company that focuses on heart diagnostics and digital health. The company has developed a portfolio of solutions based on the Coala, a patented and commercial service for remote monitoring and self-screening of heart sounds and ECG. The Coala is available direct to consumers and theCoala Pro is offered to healthcare professionals to enable smart, digital cardiac assessments.
Ferd er et familieeid investeringsselskap som er eid av femte og sjette generasjon Andresen.
Show more
Investment focus
- Energy, Software, Manufacturing
- Funding Round, Private Equity, Post-IPO Equity
- Norway, Sweden, United States
Portfolio highlights
- Ludenso — Ludenso is a software developer of AR solutions for the education industry. To make education more creative and engaging, we are giving editors, authors, and teachers the power to bring their learning resources to life through 3D models, animations, videos, and audio support. This is made possible through the Ludenso Studio, where they can createinclusive learning experiences that enables students to learn in their own way.
- wheel.me — The first and only autonomous wheel in the world. The innovation transforms anything into an autonomous mobile robot with minimal effort and without the need to alter its design or form. The company was founded in 2013 and is headquartered in Oslo, Norway.
- Nofence — Nofence is a system virtual fencing for grazing animals. Virtual fencing of livestock has been a concept long discussed in academia. The Norwegian ag-tech startup Nofence has since 2011 developed and patented a solution for virtual fencing that has proven to work. The customers say that this will become a real gamechanger for livestock managementsince pastures can easily be defined by a few clicks on a tablet/smartphone. The herd is then safely fenced in and can be monitored. The system will send notifications if something happens. From the global food security perspective, this solution will make it much easier to utilize the uncultivated land for varied and healthy pasture, and make it possible to produce more food on cultivated land.
SmiLe Inject Capital is an angel investment company to focus exclusively on early-stage life science companies.
Show more
Investment focus
- Medical, Genetics, Analytics
- Seed
- Sweden
Portfolio highlights
- Nygen Analytics — Nygen empowers researchers to unlock insights from single-cell RNA-seq data with accessible, no-code solutions, facilitating reproducible transcriptomic research.
InnovationsKapital was founded in 1994 and is a leading independent venture capital firm for innovative growth companies in the Nordic region. The business, carried out from offices in and Stockholm, Gothenburg and New York, is focused on investments within ICT and Healthcare & Life Sciences, dynamic sectors that are rapidly expanding and whereNordic research plays an important role. The capital is provided by highly reputable Swedish and international institutional investors.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Funding Round, Series B, Series C
- Sweden, Denmark, United States
Portfolio highlights
- Silecs — PiBond manufactures materials used in electronic devices, including patterning materials for semiconductors and optical materials. We also develop complete solutions that allow our clients to focus on creating innovative products.
- SantoSolve — SantoSolve is developing topical analgesic products based on non-radioactive strontium as the active substance. The Development program was initiated based on experimental clinical use of strontium-based products showing evidence of strong local analgesic effects on several localized pain conditions of both nociceptive and neuropatic origin. Nosignificant adverse effects associated with the treatment was reported.The company’s lead product, 2PX, is topically administered, utilizing dermal penetration enhancers for delivery of the active agent to its subdermal site of action. Phase I safety and pharmacology studies showed the active agent to have low systemic bioavailability, and only few and minor adverse effects were observed at the site of administration. In open label Phase II clinical trials, the product has shown strong analgesic effect in both nociceptive and neuropatic pain conditions. In follow up, placebo controlled trials, the analgesic effect of the product has been further documented. In the company’s most advanced pain indication under study, osteoarthritis, the company has recently completed the Phase II program.These trials supports the open label results and document statistically that the analgesic effect in patients treated with 2PX is superior to that observed with placebo treatment.
- Action Pharma — Action Pharma A/S operates as a research and development focused biotechnology company. It discovers and develops new drugs and treatment concepts to treat cardiovascular disease and inflammatory diseases, as well as metabolic diseases, such as type-II diabetes and obesity. The company's product pipeline includes AP214, a modifiedÃMSH-peptide analogue for the treatment of post-surgical kidney injury associated with cardiac surgery; and AP1030 and AP11 series, oral anti-diabetic (OAD) for the treatment of type-II diabetes associated with overweight/obesity. Its product pipeline also comprise AP1189, an oral anti-inflammatory compound for the treatment of inflammatory diseases, such as inflammatory bowel disease and rheumatoid arthritis; and AP405, a modified MSH peptide analogue for the treatment of inflammatory skin diseases, such as atopic dermatitis. The company was founded in 2000 and is based in Holte, Denmark.
KTH Holding is a state-owned limited company managed by KTH's University Board. It invests in promising startup companies that are based on research or teaching at KTH, with the aim of supporting commercialization and making it easier for new science to benefit society.
Show more
Investment focus
- Software, Information Technology, Biotechnology
- Funding Round, Seed, Pre-Seed
- Sweden
Portfolio highlights
First partner to exceptional teams everywhere
Show more
Investment focus
- Software, SaaS, Information Technology
- Series A, Series B, Series C
- United States, India, United Kingdom
Portfolio highlights
- Sahi — Sahi is a next-generation trading platform aimed at serious retail and professional traders in India.Sahi’s mission is to democratize access to advanced trading tools, making them available to every serious trader in India, not just institutions. The platform has seen rapid adoption, with over 200,000 app downloads and strong engagement amongactive traders.
- Campfire — Campfire is the modern accounting platform that provides core accounting and revenue automation to startups and mid-size tech companies.
- PowerUp Money — PowerUp Money: An app to get your investments right. Discover your financial freedom, and find the funds you need. Discover the age you can be financially free
Gamlegård Invest
Show more
Investment focus
- Medical, Health Care
- Seed
- Sweden
Portfolio highlights
- Linkura — Linkura offers a Lifestyle Program focusing on actions.
Zentynel Frontier is a investment firm.
Show more
Investment focus
- Health Care, Baby, Fitness
- Series A, Seed, Angel
- United States, Sweden
Portfolio highlights
- Asclepii — Asclepii is an R&D startup focused on hyper-scaling regenerative medicine through Artemis, a product that aims to turn a $30.000 cell therapy into $300.
- MultiplAI Health — Universal genomic screening for virtually any complex diseases, including cardiovascular disorders and cancer.
- Xeptiva Therapeutics — Xeptiva Therapeutics is an innovative biotech that develops novel therapies for the veterinary market
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Funding Round
- United States, Sweden, France
Portfolio highlights
- Hemab — Hemab is pioneering the first preventative treatments and functional cures for patients with rare bleeding and thrombotic disorders.
- ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
- Spruce Biosciences — Developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need
Just another WordPress site
Show more
Investment focus
- Medical, Health Care, Therapeutics
- Seed
- Sweden
Portfolio highlights
- Joint Academy — Joint Academy connects patients with licensed physical therapists to deliver online treatments for chronic joint and back pain. Our treatments are clinically proven and give patients access to a personal, licensed physical therapist, an individualized exercise plan, interactive education about the condition, and progress tracking — all through auser-friendly app. Peer-reviewed studies show that Joint Academy patients reduce their pain, change their minds about surgery, and quit painkillers. Joint Academy is now available to patients in Sweden, the US, the UK, France, and Germany.
Teknoinvest is a premier Scandinavian venture capital company. They invest in areas of emerging technologies within the ITC and Life Sciences sectors. Their main geographical scope is Scandinavia and the USA. Teknoinvest was established as the first venture capital investment company. Teknoinvest is one of the most successful VC´s in Scandinaviaaccording to track record of value created for their investors.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Funding Round, Series A
- Sweden, Norway, United States
Portfolio highlights
- GLO — glō is a venture-backed company focused on the development and commercialization of advanced LED display products using nanotechnology. The unique nanotechnology is based on 11 years of research at Lund University’s Nanometer Structure Consortium. Headed by Professor Lars Samuelson, one of the world’s leading scientists in this field, who haspublished more than 500 papers related to this technology.glō's first office is in Lund, Sweden, where basic material research continues for the next generation nanotechnology. glō's research and product development along with pilot fabrication operation is carried out at glō-USA in Sunnyvale, California. In 2016, glō established an Asia office in Taipei, Taiwan, one of the largest and fastest-growing regions for LED lighting and display applications.glō's technology sidesteps the technical limitations of current planar LED technology. It allows for the creation of highly efficient, stable and ultimately unique red, green, blue (RGB) emitters out of one material system. It aims to achieve the industry’s best color stability and ultimately enables the growth of red, green and blue emitters on the same wafer. Highly-efficient white LEDs with high color rendering will be possible without the need for phosphor conversion. It is the next enabling technology for advanced display, illumination and automotive applications.glō nanowire light-emitting diodes (nLEDs) are based on its proprietary hetero-structured semiconductor nanowire epitaxial growth and process technologies for which standard manufacturing equipment and materials can be utilized.glō currently holds over 175 patents across US, Europe and Asia. These patents are not subject to any cross-licensing with the LED oligopoly. The glō team is constantly strengthening its intellectual property position in this technology and related applications.
- SantoSolve — SantoSolve is developing topical analgesic products based on non-radioactive strontium as the active substance. The Development program was initiated based on experimental clinical use of strontium-based products showing evidence of strong local analgesic effects on several localized pain conditions of both nociceptive and neuropatic origin. Nosignificant adverse effects associated with the treatment was reported.The company’s lead product, 2PX, is topically administered, utilizing dermal penetration enhancers for delivery of the active agent to its subdermal site of action. Phase I safety and pharmacology studies showed the active agent to have low systemic bioavailability, and only few and minor adverse effects were observed at the site of administration. In open label Phase II clinical trials, the product has shown strong analgesic effect in both nociceptive and neuropatic pain conditions. In follow up, placebo controlled trials, the analgesic effect of the product has been further documented. In the company’s most advanced pain indication under study, osteoarthritis, the company has recently completed the Phase II program.These trials supports the open label results and document statistically that the analgesic effect in patients treated with 2PX is superior to that observed with placebo treatment.
- Sol Voltaics — Founded in 2007, Sol Voltaics AB is a venture-backed, development-stage nanotechnology company focused on development and commercialization of highly efficient, third-generation photovoltaic concentrator solar cells based on its proprietary heterostructured nanowire epitaxial growth and process technologies.
We partner with founders to transform unseen scientific discoveries into future breakthroughs, jointly moving businesses, people, and the world forward.
Show more
Investment focus
- Apps, Food Processing, Food and Beverage
- Seed
- Finland
Portfolio highlights
- AIATELLA — Automating medical image analysis
- Solid IO — Solid IO is transforming precision oncology with organ-on-chip technology, delivering real-time, patient-specific insights to improve cancer treatment decisions.
- SampleFacts — Next generation Dried Blood Spot sampling – separating cells and plasma at the point of collection.
FARO is an Argentina company over 10 years of experience in the development and operation of integrated projects in the agribusiness sector. All projects FARO own position it as a reference and leader both locally and internationally.Among his various projects, FARO operates the largest tree planting pecan nut Latin America, with projection tobecome the largest southern hemisphere and one of the largest in the world. This project is structured under different vehicles, including Alto Pecan stands, the first real estate development of nautical fields planted with pecan nut Latin America, located in Villa Paranacito, Entre Ríos . Another project is AgroConsortium, productive trust for the production and marketing of cereals and oilseeds in leased farms located in different productive areas in Argentina and potentially in the region. Finally, thanks to the expertise acquired in agribusiness, FARO developed his own business model for productive land conversion. Its aim is to position rural properties whose productive potential is not reflected in the price and complement the cycle with the economic use of land in intensive production, short and medium term.Since 2006, the Investor Group is a strategic partner OMBU FARO for all investment portfolios development ventures related to agribusiness, that focus on supply both local and international markets.
Show more
Investment focus
- Biotechnology, Gaming, Medical
- Series A, Seed, Funding Round
- Sweden, United States
Portfolio highlights
- Bionamic — Bionamic provides solutions for the analysis of life science data to reduce or eliminate the manual steps between raw data and results.
- Bluwhale — Unlock Web3 Wallet Potential with AI Insights. Supercharge Your Business Growth
- IntuiCell — IntuiCell develops a fundamentally new recursive computing architecture and associated technology platform.
Segulah Medical Acceleration is a Scandinavia-based investment company focusing on innovative medical technology companies in Europe.
Show more
Investment focus
- Health Care, Medical Device, Biotechnology
- Series A, Series D, Series B
- Sweden, Germany, United States
Portfolio highlights
- Protembis — ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR.The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures.Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity of TAVR.Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.
- Navinci Diagnostics — Navinci is a Swedish biotech company specializing in innovative in situ proximity ligation assay-based solutions for spatial proteomics.
- Signifier Medical Technologies — Driving Innovation in the Sleep Market Signifier Medical Technologies (SMT) is a medical technology company focused on the development and commercialisation of innovative and non-invasive solutions for patients with sleep-disordered breathing conditions and snoring. Pioneers in challenging the wisdom of conventional sleep apnoea and snoring treatments, we've created the first daytime therapy that tackles the root cause of sleep-disordered breathing by physiologically retraining the airway against collapse.
Investors by industry
Consumer
Proptech
Impact
Climate
Gaming
Biotech
FinTech
Marketplace
Community
Health Care
Hardware
Energy
Artificial intelligence
Google
EdTech
Sustainability
Venture Capital
Real Estate
Photography
Clean Energy
Education
B2B
Financial Services
Big Data
Payments
Finance
Organic Food
Food and Beverage
Web3
Infrastructure
Retail
Beauty
Publishing
Video Games
Music
Art
Wellness
Franchise
Mobile
Local
Digital Media
Legal
Android
eSports
Enterprise Software
Sports
Manufacturing
Email
Medical
Social Network
Social Media
Internet
Construction
Hospitality
Platforms
Biotechnology
Cannabis
Mobile Advertising
Travel
Fitness
Recruiting
Crowdfunding
Social
Medical Device
Automotive
Wine And Spirits
CleanTech
Mobile Apps
Transportation
InsurTech
Enterprise
LGBT
Fashion
Oil and Gas
Life Science
Theatre
Film
Non Profit
Renewable Energy
SaaS
Sporting Goods
Restaurants
Social Impact
Celebrity
Software
Cryptocurrency
Machine Learning
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
Canada
Germany
United Kingdom
Ireland
South Korea
India
Australia
New Zealand
United States
Middle East
Brazil
LATAM
Qatar
Indonesia
Asia
Europe
Spain
Belarus
Chile
Belgium
South Africa
Hong Kong
Finland
Ghana
Georgia
Ethiopia
Gibraltar
Faroe Islands
Denmark
Egypt
Estonia
Singapore
Costa Rica
Hungary
Greece
Barbados
Croatia
Belize
Bahrain
Czech Republic
Armenia
Algeria
Saudi Arabia
Ecuador
Bulgaria
Bermuda
Sri Lanka
China
Africa
Oceania
Japan
Vietnam
Kuwait
Malta
Morocco
Nicaragua
Mali
Lithuania
Peru
Lebanon
Jersey
Norway
Myanmar
Mauritius
Liberia
Mexico
Malaysia
Liechtenstein
Philippines
Italy
Israel
Panama
Poland
Senegal
Sierra Leone
Tunisia
Togo
Serbia
Turkey
San Marino
Thailand
Uzbekistan
Taiwan
Sweden
Tanzania
Slovenia
El Salvador
Portugal
Tajikistan
Ukraine
Puerto Rico
Uganda
Venezuela
Uruguay
Zambia
Zimbabwe
Rwanda
Russian Federation
Dominican Republic
Nigeria
France
Iraq
United Arab Emirates
Azerbaijan
Jamaica
Bahamas
Honduras
Iceland
Bolivia
Isle of Man
Luxembourg
Namibia
Albania
Pakistan
Kenya
Grenada
Jordan
Bangladesh
Argentina
Romania
Kazakhstan
Cayman Islands
Cambodia
Cameroon
Latvia
Cyprus
Oman
Austria
Switzerland
Colombia
Guatemala
Seychelles
Marshall Islands
VC (Venture Capital) Funds in Sweden by industry
Financial Services
Big Data
Cryptocurrency
Finance
Payments
Organic Food
Restaurants
Food and Beverage
Medical
Medical Device
Biotechnology
Wellness
Internet
Social Media
Email
Manufacturing
Art
Social Network
Digital Media
Music
Mobile
Android
Legal
Construction
Software
Sports
eSports
Fitness
Hospitality
CleanTech
Travel
Automotive
InsurTech
Recruiting
FinTech
Enterprise
Consumer
Sustainability
EdTech
Climate
Energy
SaaS
Impact
Proptech
Marketplace
Artificial intelligence
Community
Hardware
Gaming
Retail
Infrastructure
Fashion
Web3
B2B
Life Science
Video Games
Photography
Publishing
Wine And Spirits
Education
Clean Energy
Renewable Energy
Real Estate
Biotech
Enterprise Software
Transportation
Health Care
Social Impact
Mobile Apps
Blockchain
Media (entertainment)
Agriculture (agtech)
Machine Learning
Platforms